Literature DB >> 7001174

Portal and peripheral vein concentrations of insulin and glucagon after arginine infusion in morbidly obese subjects.

R M Walter, E M Gold, C A Michas, J W Ensinck.   

Abstract

Five morbidity obese subjects with fasting normoglycemia underwent catheterization of portal and peripheral veins immediately prior to jejunoileal bypass surgery. Levels of immunoreactive insulin (IRI), immunoreactive glucagon (IRG), and glucose were determined in simultaneously obtained serum samples before and after infusion of arginine. Portal levels exceeded peripheral levels by at least 50% with IRI and by 30%-40% with IRG. These results were similar to those reported in nonobese subjects and show that in morbid obesity as well as in nonobese states, peripheral insulin to glucagon molar ratios (I/G) underestimate portal I/G. Although hepatic extraction was not specifically measured, the data suggest that the peripheral levels of insulin and glucagon reported in morbid obesity result from alterations in secretion and not altered extraction.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7001174     DOI: 10.1016/0026-0495(80)90213-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

1.  Glucagon receptor of human liver. Studies of its molecular weight and binding properties, and its ability to activate hepatic adenylyl cyclase of non-obese and obese subjects.

Authors:  J N Livingston; K Einarsson; L Backman; S Ewerth; P Arner
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

2.  Splanchnic insulin metabolism in obesity. Influence of body fat distribution.

Authors:  A N Peiris; R A Mueller; G A Smith; M F Struve; A H Kissebah
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

3.  Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man.

Authors:  S G Rosen; W E Clutter; M A Berk; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

4.  Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.

Authors:  D R Hoelzer; G P Dalsky; W E Clutter; S D Shah; J O Holloszy; P E Cryer
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

5.  Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion.

Authors:  T F Tse; W E Clutter; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

6.  The effect of parenteral and enteral nutrition on portal and systemic immunoreactivities of gastrin, glucagon and vasoactive intestinal polypeptide (VIP).

Authors:  Z Gimmon; R F Murphy; M H Chen; C A Nachbauer; J E Fischer; S N Joffe
Journal:  Ann Surg       Date:  1982-11       Impact factor: 12.969

7.  Enzyme activity patterns of phosphoenolpyruvate carboxykinase, pyruvate kinase, glucose-6-phosphate-dehydrogenase and malic enzyme in human liver.

Authors:  M Wimmer; C Luttringer; M Colombi
Journal:  Histochemistry       Date:  1990

8.  The Impact of Amino Acids on Postprandial Glucose and Insulin Kinetics in Humans: A Quantitative Overview.

Authors:  Bart van Sloun; Gijs H Goossens; Balazs Erdos; Michael Lenz; Natal van Riel; Ilja C W Arts
Journal:  Nutrients       Date:  2020-10-21       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.